Pediatrics HOT COVID-19 Database in NY Tristate

NCT04445402 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 77

Last updated 2023-05-03

No results posted yet for this study

Summary

New York City (NYC) has become the epicenter of the worldwide pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). By collecting and summarizing the experience with other major health care providers in the tristate (New York (NY), New Jersey (NJ) and Connecticut (CT)) are, the investigators are uniquely positioned to inform the rest of the country about what to expect and how to manage children and young adults with hematological, oncological or stem cell transplant diagnoses during the pandemic.

Conditions

  • Pediatric Cancer
  • Immune System Disorder
  • COVID-19
  • Hemoglobinopathies

Sponsors & Collaborators

Principal Investigators

  • Prakash Satwani, MD · Columbia University

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-30
Primary Completion
2022-09-12
Completion
2022-09-12

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04445402 on ClinicalTrials.gov